MedPath

Examination concerning utility of relapse prevention of factor and ursodeoxycholic acid related to relapse after total biliary stone is removed

Not Applicable
Conditions
After removing a total biliary stone
Registration Number
JPRN-UMIN000003732
Lead Sponsor
Hiroshima University hospital Department of General Internal Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
360
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patient who has received treatment of gastrectomy 2.Patient who has received treatment by malignant tumor 3.Patient whom biliary tract completely blockaded 4.Patient who has received treatment due to fulminant hepatitis 5.Patient who is scheduling patient and pregnancy with symptom of pregnancy while suckling while getting pregnant 6.Patient of alcoholism 7.Patient who has the past of hypersensitivity for experimental drug 8.Patient who has received treatment with medicine made of bile acid ([uruso]and[chinokapuseru],etc.), bile acid absorbents([korebain]and quest orchis),profit pluck medicines(dehydrocholic acid note, spa curl,[ferubiden],and[inchinkoutou],etc.),and medicines under development 9.Additionally, patient whom research responsibility doctor etc.judged to be suitable case as target in present study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath